December 11, 2015
Weil is advising Dow Chemical Company in its $130 billion merger of equals with E. I. du Pont de Nemours and Company. The parties intend to pursue a spin-off of three of its businesses – agriculture, material sciences and specialty products – following the merger. The deal is expected to close in the second half of 2016 and is subject to customary closing conditions.
The Weil team is led by Corporate Chairman Michael Aiello and includes M&A partners James Griffin and Sachin Kohli (effective January 1, 2016); Executive Compensation & Benefits head Paul Wessel and partner Amy Rubin; Capital Markets partner Corey Chivers; Litigation co-chair David Lender and partner Theodore Tsekerides; Banking & Finance head Douglas Urquhart; Executive Compensation & Benefits counsel Steven Margolis; M&A associates Megan Pendleton, Jakob Deitch, Michelle Sargent and Francesca Cohen (not yet admitted); Tax associate Daniel Barron; Executive Compensation & Benefits associate Amanda Rosenblum; Capital Markets associate Aman Singh; Litigation associates Jodi Barrow and Caroline Toole; Banking & Finance associates Justin C. Lee and Philip Ratner; and Structured Finance & Derivatives associates Shawn Kodes, Daniel Lee and Maia Pelleg.